Overview

Global Microfluidics Market is estimated to value over USD 64 billion by 2026 end and record a CAGR of over 19.4% during the forecast period 2019 to 2026.

The global microfluidics market growth is steered by the growing insistence for point-of-care (POC) testing, rising prevalence of persistent diseases, quicker turn-around analysis time and improvements in device portability.

Point-of-care testing permits healthcare professionals to conduct the patient diagnosis in an ambulance, the physician’s office, at field, hospital or at home. Devices assisted with microfluidic technology are currently deployed for point-of–care testing owing to their requirement of small sample volumes and they use channels that are micro-fabricated for analysing samples. Devices used for POC testing are already widely used in blood, HIV, glucose and haemoglobin testing sectors. The POC testing devices of the future would possibly emphasize on cancer and antibiotics therapies.

The POC testing devices that are based on the microfluidic technique have massive potential in the developed as well as developing nations, owing to the high amount of population affected by such diseases.

The clinical diagnostics segment is likely to hold the largest global microfluidics market share and is predicted to exhibit a substantial growth rate over the forecast time frame.

A substantial area of application for microfluidics is clinical diagnostics. Diseases, for instance, toxicity, can be identified by undertaking multiple biochemical analysis procedures and by symptom observation. The changes occurring in the blood of the patients can signify organ dysfunction or damage, before observable damages of the microscopic cells or other kinds of symptoms.

There has been an increase in the insistence for the development of an inexpensive and easy-to-handle biochip for clinical diagnostics by using plastic microfluidic chips that are fully integrated and which have the identifying or sampling capability of reliable and fast metabolic parameter measurements from a patient and that too with no or minimal invasion. Therefore, the augmentation of clinical diagnostics is predicted to aid the expansion of the global microfluidics market size.

The North America region accounts the largest microfluidics market share and it is predicted to continue its domination over the forecast period. This is credited to factors, for instance, the better reimbursement policies coupled with a well-established healthcare system and the higher adoption rate of advanced therapies amongst the population. Microfluidics is growing at a meteoric pace, especially in the U.S, with respect to massive budget sanctions for research and development. Point-of-care and molecular diagnostics primarily use microfluidic techniques for multiple applications, and thus, they account a large market share in the U.S. Due to this, the U.S holds most of the market share in the North American region.

Major market players included in the global microfluidics industry are Danaher, Thermo Fisher Scientific, Perkinelmer, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson and Co., Illumina, F. Hoffmann-La Roche, Fluidigm Corp., Dolomite Microfludics, Qiagen, Abbott Laboratories, Biomerieux, Microfludic Chipshop, Elveflow, Celix, Micronit Microtechnologies.

Global Microfluidics Market Segmentation:

By Application

• In-Vitro Diagnostics

- Point-of-Care Testing

- Clinical Diagnostics

• Pharmaceutical and Life Science Research

- Lab Analytics

~ Proteomic Analysis

~ Genomic Analysis

~ Cell-Based Assays

~ Capillary Electrophoresis

- Microdispensing

- Microreaction

• Drug Delivery
• Laboratory Testing

- Agro Food Testing

- Industrial Testing

- Environmental Testing

By Component   

• By Type

- Microfluidic Chips

- Microfluidic Sensors

- Micropumps

- Microneedles

- Other Components

• By Material

- Polymer

- Glass

- Silicon

- Other Materials

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global microfluidics market by application, by component and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Definition 

1.3 Scope of the Study 

        1.3.1 Markets Covered

1.4 Years Considered for the Study 

1.5 Currency 

1.6 Limitations 

1.7 Stakeholders 

2 Research Methodology 

2.1 Research Data 

        2.1.1 Secondary Data

                 2.1.1.1 Key Data From Secondary Sources

        2.1.2 Primary Data

                 2.1.2.1 Key Data From Primary Sources

                 2.1.2.2 Key Industry Insights

2.2 Market Size Estimation 

        2.2.1 Bottom-Up Approach

        2.2.2 Top-Down Approach

2.3 Market Breakdown and Data Triangulation 

2.4 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 

4.1 Growth Potential of the Microfluidics Market 

4.2 Asia Pacific Microfluidic Components Market, By Material 

4.3 Geographic Growth Opportunities 

4.4 By Geography 

4.5 Developing vs Developed Countries 

5 Market Overview 

5.1 Introduction 

5.2 microfluidics Market Dynamics 

        5.2.1 Drivers

                 5.2.1.1 Rising Demand for Point-Of-Care Testing

                 5.2.1.2 Fast Returns on Investment

                 5.2.1.3 Faster Testing and Improved Portability Through Microfluidic Chip Miniaturization

                 5.2.1.4 Entry of New Players and Launch of New and Advanced Products

        5.2.2 Restraints

                 5.2.2.1 Complex and Time-Consuming Regulatory Approval Process

                 5.2.2.2 Incorporation of Microfluidics Technology Into Existing Workflows

        5.2.3 Opportunities

                 5.2.3.1 Asia as A Key Growth Hotspot

                 5.2.3.2 Expanding Applications of Drug Delivery Technologies

                 5.2.3.3 Growing Applications of Microfluidics Technology

        5.2.4 Challenge

                 5.2.4.1 Standardization/Commercialization of Microfluidic Devices

6 Industry Insights

6.1 Introduction 

6.2 Industry Trends 

        6.2.1 Shifting Trend Toward the Adoption of Polymers

        6.2.2 Universities Actively Generating Microfluidic Startups and Large Players Acquiring Small Players

6.3 Parent Markets Analysis 

6.4 Evolution of Microfluidics Technology in Healthcare 

6.5 Value Chain Analysis 

        6.5.1 Microfluidic Components Procurement Model of Major Players

7 Microfluidics Market, By Application 

7.1 Introduction 

7.2 in Vitro Diagnostics 

        7.2.1 Point-Of-Care Testing

        7.2.2 Clinical Diagnostics

7.3 Pharmaceutical and Life Science Research 

        7.3.1 Lab Analytics

                 7.3.1.1 Proteomic Analysis

                 7.3.1.2 Genomic Analysis

                 7.3.1.3 Cell-Based Assays

                 7.3.1.4 Capillary Electrophoresis

        7.3.2 Microdispensing

        7.3.3 Microreaction

7.4 Drug Delivery 

7.5 Laboratory Testing 

        7.5.1 Agro Food Testing

        7.5.2 Industrial Testing

        7.5.3 Environmental Testing

8 Microfluidic Components Market 

8.1 Microfluidic Components Market, By Type 

        8.1.1 Microfluidic Chips

        8.1.2 Microfluidic Sensors

        8.1.3 Micropumps

        8.1.4 Microneedles

        8.1.5 Other Components

8.2 Microfluidic Components Market, By Material 

        8.2.1 Polymer

        8.2.2 Glass

        8.2.3 Silicon

        8.2.4 Other Materials

9 By Region 

9.1 Introduction 

9.2 North America 

        9.2.1 US

        9.2.2 Canada

9.3 Europe 

        9.3.1 Germany

        9.3.2 France

        9.3.3 UK

        9.3.4 Italy

        9.3.5 Spain

        9.3.6 Rest of Europe

9.4 Asia Pacific 

        9.4.1 Japan

        9.4.2 China

        9.4.3 India

        9.4.4 Rest of Asia Pacific

9.5 Latin America 

9.6 Middle East & Africa 

10 Competitive Landscape 

  10.1 Overview 

  10.2 Product Portfolio Matrix 

  10.3 Competitive Situations and Trends 

          10.3.1 Product Launches

          10.3.2 Partnerships, Agreements, and Collaborations

          10.3.3 Acquisitions

          10.3.4 Expansions

11 Company Profiles 

  11.1 Danaher Corporation 

  11.2 Thermo Fisher Scientific 

  11.3 Perkinelmer 

  11.4 Agilent Technologies 

  11.5 Bio-Rad Laboratories 

  11.6 Becton, Dickinson and Company 

  11.7 Illumina 

  11.8 F. Hoffmann-La Roche 

  11.9 Fluidigm Corporation 

  11.10 Dolomite Microfluidics 

  11.11 Qiagen 

  11.12 Abbott Laboratories 

  11.13 Biomérieux 

  11.14 Microfluidic Chipshop 

  11.15 Elveflow 

  11.16 Cellix 

  11.17 Micronit Microtechnologies

Chapter 12 Research Finding and Conclusion 

Chapter 13  Research Methodology 

Chapter 14  Research Data Source   

Tables

Figures